Cargando…
1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe complication of SARS-CoV-2. Identifying clinical and demographic characteristics associated with MIS-C mortality and description of MIS-C decedents over time may help identify children at increased risk for poor o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676941/ http://dx.doi.org/10.1093/ofid/ofad500.067 |
_version_ | 1785150012672442368 |
---|---|
author | Yousaf, Anna R Lindsey, Katherine N Shah, Ami B Miller, Allison D Wu, Michael J Melgar, Michael Zambrano, Laura D Campbell, Angela P |
author_facet | Yousaf, Anna R Lindsey, Katherine N Shah, Ami B Miller, Allison D Wu, Michael J Melgar, Michael Zambrano, Laura D Campbell, Angela P |
author_sort | Yousaf, Anna R |
collection | PubMed |
description | BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe complication of SARS-CoV-2. Identifying clinical and demographic characteristics associated with MIS-C mortality and description of MIS-C decedents over time may help identify children at increased risk for poor outcomes and potentially inform treatment decisions. METHODS: This investigation included all MIS-C cases with known outcome reported to CDC MIS-C national surveillance from February 2020─December 2022. Clinical and demographic characteristics were compared between survivors and decedents. Decedents were described over time and classified by date of MIS-C illness onset into five pandemic waves corresponding to five peaks of MIS-C activity (Figure 1): (1) 2/19/2020─6/28/2020, (2) 6/29/2020─10/17/2020, (3) 10/18/2020─7/8/2021, (4) 7/9/2021─12/7/ 2021, and (5) 12/8/2021─12/31/2022. Waves 4 and 5 were periods of predominant Delta and Omicron SARS-CoV-2 variant circulation, respectively. [Figure: see text] RESULTS: Seventy-six decedents and 8,691 survivors were reported (Table). A higher proportion of decedents compared with survivors were aged 16-20 years (41% vs 9%; p< 0.01), from the South (55% vs 41%; p=0.01) and had MIS-C illness onset in wave 1 (18% vs 7%; p< .01). Half (51%) of decedents had an underlying medical condition compared with 24% of survivors (p< 0.01). A higher proportion of decedents than survivors had severe cardiovascular (95% vs 76%), respiratory (99% vs 36%), renal (59% vs 19%), and neurologic (30% vs 4%) involvement, and fewer had mucocutaneous (33% vs 75%). Deaths in the 16-20 age group were predominant in waves 1-4 but comprised only 15% of deaths in wave 5, when 57% of decedents were aged 0-4 years (Figure 2). Race and ethnicity of decedents varied over time. Severe cardiovascular and respiratory involvement was high ( >85-100%) over time in decedents; other organ manifestations varied by MIS-C wave. [Figure: see text] [Figure: see text] CONCLUSION: Older age (16-20 years), residing in the South, illness early in the pandemic, underlying medical conditions, and severe organ involvement were all significantly associated with death among children with MIS-C. MIS-C decedent characteristics are dynamic and may continue to evolve with changes in underlying population immunity, SARS-CoV-2 transmission, and variant emergence. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-10676941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106769412023-11-27 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022 Yousaf, Anna R Lindsey, Katherine N Shah, Ami B Miller, Allison D Wu, Michael J Melgar, Michael Zambrano, Laura D Campbell, Angela P Open Forum Infect Dis Abstract BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe complication of SARS-CoV-2. Identifying clinical and demographic characteristics associated with MIS-C mortality and description of MIS-C decedents over time may help identify children at increased risk for poor outcomes and potentially inform treatment decisions. METHODS: This investigation included all MIS-C cases with known outcome reported to CDC MIS-C national surveillance from February 2020─December 2022. Clinical and demographic characteristics were compared between survivors and decedents. Decedents were described over time and classified by date of MIS-C illness onset into five pandemic waves corresponding to five peaks of MIS-C activity (Figure 1): (1) 2/19/2020─6/28/2020, (2) 6/29/2020─10/17/2020, (3) 10/18/2020─7/8/2021, (4) 7/9/2021─12/7/ 2021, and (5) 12/8/2021─12/31/2022. Waves 4 and 5 were periods of predominant Delta and Omicron SARS-CoV-2 variant circulation, respectively. [Figure: see text] RESULTS: Seventy-six decedents and 8,691 survivors were reported (Table). A higher proportion of decedents compared with survivors were aged 16-20 years (41% vs 9%; p< 0.01), from the South (55% vs 41%; p=0.01) and had MIS-C illness onset in wave 1 (18% vs 7%; p< .01). Half (51%) of decedents had an underlying medical condition compared with 24% of survivors (p< 0.01). A higher proportion of decedents than survivors had severe cardiovascular (95% vs 76%), respiratory (99% vs 36%), renal (59% vs 19%), and neurologic (30% vs 4%) involvement, and fewer had mucocutaneous (33% vs 75%). Deaths in the 16-20 age group were predominant in waves 1-4 but comprised only 15% of deaths in wave 5, when 57% of decedents were aged 0-4 years (Figure 2). Race and ethnicity of decedents varied over time. Severe cardiovascular and respiratory involvement was high ( >85-100%) over time in decedents; other organ manifestations varied by MIS-C wave. [Figure: see text] [Figure: see text] CONCLUSION: Older age (16-20 years), residing in the South, illness early in the pandemic, underlying medical conditions, and severe organ involvement were all significantly associated with death among children with MIS-C. MIS-C decedent characteristics are dynamic and may continue to evolve with changes in underlying population immunity, SARS-CoV-2 transmission, and variant emergence. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10676941/ http://dx.doi.org/10.1093/ofid/ofad500.067 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Yousaf, Anna R Lindsey, Katherine N Shah, Ami B Miller, Allison D Wu, Michael J Melgar, Michael Zambrano, Laura D Campbell, Angela P 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022 |
title | 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022 |
title_full | 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022 |
title_fullStr | 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022 |
title_full_unstemmed | 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022 |
title_short | 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022 |
title_sort | 1094. comparison of demographic and clinical characteristics in survivors vs. decedents with multisystem inflammatory syndrome in children (mis-c) during the covid-19 pandemic—cdc national surveillance, february 2020-december 2022 |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676941/ http://dx.doi.org/10.1093/ofid/ofad500.067 |
work_keys_str_mv | AT yousafannar 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022 AT lindseykatherinen 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022 AT shahamib 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022 AT millerallisond 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022 AT wumichaelj 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022 AT melgarmichael 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022 AT zambranolaurad 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022 AT campbellangelap 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022 |